These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Advanced course of Parkinson disease. Little improved motion with continuous intestinal levodopa administration]. Oberpichler-Schwenk H. Med Monatsschr Pharm; 2005 Jul 15; 28(7):245-6. PubMed ID: 16038123 [No Abstract] [Full Text] [Related]
23. Combined general and regional anesthetic in a child with aromatic L-amino acid decarboxylase deficiency. Berkowitz DH, Ganesh A. Anesth Analg; 2006 Dec 15; 103(6):1630-1. PubMed ID: 17122302 [No Abstract] [Full Text] [Related]
24. Abnormal glucose metabolism in aromatic L-amino acid decarboxylase deficiency. Ide S, Sasaki M, Kato M, Shiihara T, Kinoshita S, Takahashi JY, Goto Y. Brain Dev; 2010 Jun 15; 32(6):506-10. PubMed ID: 19520530 [Abstract] [Full Text] [Related]
25. Pharmacoscintigraphic and pharmacokinetic evaluation on healthy human volunteers of sustained-release floating minitablets containing levodopa and carbidopa. Goole J, Van Gansbeke B, Pilcer G, Deleuze P, Blocklet D, Goldman S, Pandolfo M, Vanderbist F, Amighi K. Int J Pharm; 2008 Nov 19; 364(1):54-63. PubMed ID: 18778758 [Abstract] [Full Text] [Related]
26. Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family. Maller A, Hyland K, Milstien S, Biaggioni I, Butler IJ. J Child Neurol; 1997 Sep 19; 12(6):349-54. PubMed ID: 9309516 [Abstract] [Full Text] [Related]
27. Aromatic l-aminoacid decarboxylase deficiency: unusual neonatal presentation and additional findings in organic acid analysis. Abdenur JE, Abeling N, Specola N, Jorge L, Schenone AB, van Cruchten AC, Chamoles NA. Mol Genet Metab; 2006 Jan 19; 87(1):48-53. PubMed ID: 16288991 [Abstract] [Full Text] [Related]
28. Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. Prescrire Int; 2005 Apr 19; 14(76):51-4. PubMed ID: 15875340 [Abstract] [Full Text] [Related]
29. Levodopa can worsen tremor associated with dystonia. Hensman DJ, Bain PG. Mov Disord; 2006 Oct 19; 21(10):1778-80. PubMed ID: 16856131 [Abstract] [Full Text] [Related]
30. [Long term experience with Stalevo in Szeged, Hungary]. Klivényi P, Vécsei L. Ideggyogy Sz; 2009 May 30; 62(5-6):178-80. PubMed ID: 19579666 [Abstract] [Full Text] [Related]
31. A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: from molecular mechanisms to therapy implications. Montioli R, Dindo M, Giorgetti A, Piccoli S, Cellini B, Voltattorni CB. Hum Mol Genet; 2014 Oct 15; 23(20):5429-40. PubMed ID: 24865461 [Abstract] [Full Text] [Related]
32. Duodenal levodopa infusion monotherapy vs oral polypharmacy in advanced Parkinson disease. Nyholm D, Nilsson Remahl AI, Dizdar N, Constantinescu R, Holmberg B, Jansson R, Aquilonius SM, Askmark H. Neurology; 2005 Jan 25; 64(2):216-23. PubMed ID: 15668416 [Abstract] [Full Text] [Related]
34. The role of amino acid decarboxylase in the stimulation of gastrin release in man. Etienne M, Brassinne A. Gastroenterol Clin Biol; 1989 Jan 25; 13(1):14-7. PubMed ID: 2925041 [Abstract] [Full Text] [Related]
35. Anesthesia management in a young child with aromatic l-amino acid decarboxylase deficiency. Vutskits L, Menache C, Manzano S, Haenggeli CA, Habre W. Paediatr Anaesth; 2006 Jan 25; 16(1):82-4. PubMed ID: 16409536 [Abstract] [Full Text] [Related]
36. Aromatic L-amino acid decarboxylase deficiency associated with epilepsy mimicking non-epileptic involuntary movements. Ito S, Nakayama T, Ide S, Ito Y, Oguni H, Goto Y, Osawa M. Dev Med Child Neurol; 2008 Nov 25; 50(11):876-8. PubMed ID: 18754761 [Abstract] [Full Text] [Related]
37. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety]. Annic A, Devos D, Seguy D, Dujardin K, Destée A, Defebvre L. Rev Neurol (Paris); 2009 Nov 25; 165(8-9):718-27. PubMed ID: 19150100 [Abstract] [Full Text] [Related]
38. Clinical efficacy of a single afternoon dose of effervescent levodopa-carbidopa preparation (CHF 1512) in fluctuating Parkinson disease. Stocchi F, Fabbri L, Vecsei L, Krygowska-Wajs A, Monici Preti PA, Ruggieri SA. Clin Neuropharmacol; 2007 Nov 25; 30(1):18-24. PubMed ID: 17272966 [Abstract] [Full Text] [Related]
39. Myoclonus-dystonia syndrome with severe depression is caused by an exon-skipping mutation in the epsilon-sarcoglycan gene. Misbahuddin A, Placzek M, Lennox G, Taanman JW, Warner TT. Mov Disord; 2007 Jun 15; 22(8):1173-5. PubMed ID: 17230465 [Abstract] [Full Text] [Related]
40. Pathobiochemical implications of hyperdopaminuria in patients with aromatic L-amino acid decarboxylase deficiency. Abeling NG, Bräutigam C, Hoffmann GF, Barth PG, Wevers RA, Jaeken J, Fiumara A, Knust A, van Gennip AH. J Inherit Metab Dis; 2000 Jun 15; 23(4):325-8. PubMed ID: 10896285 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]